Y-mAbs Therapeutics, Inc. (YMAB)

Y-mAbs Therapeutics Revenue

Y-mAbs Therapeutics had revenue of $19.53M in the quarter ending June 30, 2025, a decrease of -14.36%. This brings the company's revenue in the last twelve months to $85.39M, down -1.34% year-over-year. In the year 2024, Y-mAbs Therapeutics had annual revenue of $87.69M with 3.38% growth.

• Revenue (ttm): $85.39M
• Revenue Growth: -1.34%
• P/S Ratio: 4.49
• Revenue / Employee: $821,010
• Employees: 104
• Market Cap: 387.59M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	87.69M	2.87M	3.38%
Dec 31, 2023	84.82M	19.55M	29.96%
Dec 31, 2022	65.27M	30.37M	87.03%
Dec 31, 2021	34.90M	14.15M	68.18%
Dec 31, 2020	20.75M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.